K. Gréen

689 total citations
16 papers, 540 citations indexed

About

K. Gréen is a scholar working on Public Health, Environmental and Occupational Health, Pharmacology and Genetics. According to data from OpenAlex, K. Gréen has authored 16 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Public Health, Environmental and Occupational Health, 6 papers in Pharmacology and 5 papers in Genetics. Recurrent topics in K. Gréen's work include Pregnancy and Medication Impact (7 papers), Inflammatory mediators and NSAID effects (6 papers) and Estrogen and related hormone effects (5 papers). K. Gréen is often cited by papers focused on Pregnancy and Medication Impact (7 papers), Inflammatory mediators and NSAID effects (6 papers) and Estrogen and related hormone effects (5 papers). K. Gréen collaborates with scholars based in Sweden, United States and Bulgaria. K. Gréen's co-authors include N. Wiqvist, Bengt Samuelsson, M. Bygdeman, M. Toppozada, Elisabeth Granström, V. Lundström, Udo Axen, James N. Martin, Staffan Bergström and S. Bergström and has published in prestigious journals such as Analytical Biochemistry, American Journal of Obstetrics and Gynecology and Cellular and Molecular Life Sciences.

In The Last Decade

K. Gréen

16 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Gréen Sweden 10 246 144 111 85 62 16 540
Pär Westlund Sweden 13 142 0.6× 135 0.9× 81 0.7× 157 1.8× 9 0.1× 26 679
K. Green Sweden 10 92 0.4× 197 1.4× 87 0.8× 23 0.3× 18 0.3× 13 389
T Kodama Japan 10 53 0.2× 22 0.2× 98 0.9× 23 0.3× 30 0.5× 58 713
John E. Plager United States 16 45 0.2× 35 0.2× 73 0.7× 11 0.1× 37 0.6× 31 797
Delphine Marez France 13 76 0.3× 253 1.8× 84 0.8× 46 0.5× 21 0.3× 15 857
C. H. L. Shackleton United States 10 53 0.2× 52 0.4× 42 0.4× 19 0.2× 64 1.0× 14 585
Chull S. Song United States 12 33 0.1× 41 0.3× 52 0.5× 21 0.2× 32 0.5× 21 535
B. Marchant United Kingdom 11 75 0.3× 27 0.2× 71 0.6× 8 0.1× 26 0.4× 17 524
Dany Chevalier France 15 48 0.2× 163 1.1× 52 0.5× 90 1.1× 16 0.3× 23 589
Radosław Jaźwiec Poland 12 35 0.1× 75 0.5× 41 0.4× 26 0.3× 37 0.6× 31 553

Countries citing papers authored by K. Gréen

Since Specialization
Citations

This map shows the geographic impact of K. Gréen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Gréen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Gréen more than expected).

Fields of papers citing papers by K. Gréen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Gréen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Gréen. The network helps show where K. Gréen may publish in the future.

Co-authorship network of co-authors of K. Gréen

This figure shows the co-authorship network connecting the top 25 collaborators of K. Gréen. A scholar is included among the top collaborators of K. Gréen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Gréen. K. Gréen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Gréen, K., et al.. (1983). Gas chromatographic — Mass spectrometric quantitation of 16,16-dimethyl-trans-Δ2-PGE1. Prostaglandins. 25(2). 225–235. 13 indexed citations
2.
Abrahamsson, S., K. Gréen, Lars Hellgren, & J. Vincent. (1980). Evidence that the prostaglandin-like substances fromPropionibacterium acnes are not identical with PGE2. Cellular and Molecular Life Sciences. 36(1). 58–58. 8 indexed citations
3.
Gréen, K., et al.. (1980). Quantitative determination of 9-deoxo-16,16-dimethyl-9-methylene-PGE2 in human plasma by GC-MS, RIA and HPLC. Prostaglandins. 20(4). 767–780. 7 indexed citations
4.
Wiqvist, N., V. Lundström, & K. Gréen. (1976). PREMATURE LABOR AND INDOMETHACIN. Obstetrical & Gynecological Survey. 31(6). 483–484. 1 indexed citations
5.
Martin, James N., M. Bygdeman, Mohamed Ramadan, et al.. (1976). Vaginally administered 16,16-dimethyl-PGE2 for the induction of midtrimester abortion. Prostaglandins. 11(1). 123–132. 17 indexed citations
6.
Bygdeman, M., et al.. (1975). Vaginally administered 16, 16-dimethyl-prostaglandin E2 as an agent for pre-operative cervical dilatation. Prostaglandins. 10(2). 357–364. 8 indexed citations
7.
Bygdeman, M., et al.. (1975). Vaginally administered 16, 16-dimethyl-prostaglandin E2 as an agent for pre-operative cervical dilatation. Prostaglandins. 10(4). 357–364. 9 indexed citations
8.
Wiqvist, N., V. Lundström, & K. Gréen. (1975). Premature labor and indomethacin. Prostaglandins. 10(3). 515–526. 60 indexed citations
9.
Gréen, K., M. Bygdeman, M. Toppozada, & N. Wiqvist. (1974). The role of prostaglandin F2α in human parturition. American Journal of Obstetrics and Gynecology. 120(1). 25–31. 129 indexed citations
10.
Wiqvist, N., M. Bygdeman, K. Gréen, & V. Lundström. (1974). ENDOGENOUS PROSTAGLANDINS AND THE INITIATION OF LABOR. Acta Obstetricia Et Gynecologica Scandinavica. 53(S37). 7–16. 9 indexed citations
11.
Bygdeman, M., K. Gréen, M. Toppozada, N. Wiqvist, & S. Bergström. (1974). The influence of prostaglandin metabolites on the uterine response to PGF2α. A clinical and pharmacokinetic study. Life Sciences. 14(3). 521–531. 28 indexed citations
12.
Bygdeman, M., James N. Martin, N. Wiqvist, K. Gréen, & Staffan Bergström. (1974). Reassessment of systemic administration of prostaglandins for induction of midtrimester abortion. Prostaglandins. 8(2). 157–169. 42 indexed citations
13.
Samuelsson, Bengt & K. Gréen. (1974). Endogenous levels of 15-keto-dihydro-prostaglandins in human plasma. Biochemical Medicine. 11(3). 298–303. 72 indexed citations
14.
Granström, Elisabeth, K. Gréen, M. Bygdeman, M. Toppozada, & N. Wiqvist. (1973). Metabolic and quantitative studies in connection with intraamniotic administration of prostaglandin F2α for induction of therapeutic abortion. Life Sciences. 12(5). 219–229. 11 indexed citations
15.
16.
Béguin, François, M. Bygdeman, K. Gréen, et al.. (1972). Analysis of Prostaglandin F2a, and Metabolites in Blood during Constant Intravenous Infusion of Prostaglandin F2a, in the Human Female. Acta Physiologica Scandinavica. 86(3). 430–432. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pär Westlund Breakdown of academic impact, for papers by K. Green Breakdown of academic impact, for papers by T Kodama Breakdown of academic impact, for papers by John E. Plager Breakdown of academic impact, for papers by Delphine Marez Breakdown of academic impact, for papers by C. H. L. Shackleton Breakdown of academic impact, for papers by Chull S. Song Breakdown of academic impact, for papers by B. Marchant Breakdown of academic impact, for papers by Dany Chevalier Breakdown of academic impact, for papers by Radosław Jaźwiec
Rankless by CCL
2026